Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial
Mads Ersbøll, Mikkel Jürgens, Philip Hasbak, Andreas Kjær, Emil Wolsk, Bo Zerahn, Niels Brandt, Peter Gæde, Peter Rossing, Jens Faber, Silvio E. Inzucchi, Finn Gustafsson, Morten Schou, Caroline Kistorp
Topics & Concepts
EmpagliflozinMedicinePlaceboCardiologyInternal medicineDiabetes mellitusType 2 diabetesDiastoleBody mass indexEjection fractionBlood pressureHeart failureEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementCardiovascular Function and Risk FactorsMetabolism, Diabetes, and Cancer